+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact)

  • ID: 5232207
  • Report
  • November 2020
  • Region: Global
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging SpA
  • GE Healthcare LLC
  • Guerbet SA
  • Lantheus Medical Imaging
  • MORE
Summary

Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.

The model discusses in detail the impact of COVID-19 on Contrast Agents market for the year 2020 and beyond. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computated tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among other modalities. Within CT, non-ionic iodinated agents are preferred over ionic iodinated agents for most CT procedures. Barium-based agents are generally used for imaging the GI tract. MRI contrast agents can be used for a variety of procedures, while ultrasound contrast agents are currently mainly used for echocardiograms.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Contrast Agents and evolving competitive landscape -
  • Insightful review of the key industry trends.
  • Annualized total Contrast Agents market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, the publisher analysts provide unique country specific insights on the market.
  • SWOT analysis for Contrast Agents market.
  • Competitive dynamics insights and trends provided for Contrast Agents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies Covered:

Bayer AG, GE Healthcare LLC, Guerbet SA, Bracco Imaging SpA, Lantheus Medical Imaging, and Others

Countries Covered:

United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
  • CMO executives who must have deep understanding of the Contrast Agents marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy

The model will enable you to -
  • Understand the impact of COVID-19 on Contrast Agents market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Contrast Agents market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Contrast Agents market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Contrast Agents market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Note: Product cover images may vary from those shown
2 of 2
  • Bayer AG
  • GE Healthcare LLC
  • Guerbet SA
  • Bracco Imaging SpA
  • Lantheus Medical Imaging
Note: Product cover images may vary from those shown
Adroll
adroll